Skip to search formSkip to main contentSkip to account menu

PNU 140690

Known as: PNU-140690 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

tipranavir

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Inhibitors Multidrug Resistance to Other Protease Isolates Derived from Patients with Human Immunodeficiency Virus Type 1 Susceptibility to PNU-140690 (Tipranavir) of
In our study we examined the anti-human immunodeficiency virus type 1 (anti-HIV-1) activity of a novelHIV-1 protease inhibitor… 
2004
2004
Tipranavir: the first nonpeptidic protease inhibitor.
Resistance to anti-HIV medications is an ongoing dilemma. A recent study in 16 European countries and Israel found primary drug… 
2001
2001
Discovery Screening Of The In Vitro Cytochrome P450 Inhibitory Potency Of HIV-Protease Inhibitors : Comparison To Saquinavir, Indinavir, Nelfinavir, And PNU 140690
HIV-1 protease inhibitors are an important part of the arsenal for the treatment of AIDS. Currently available protease inhibitors… 
1998
1998
Notes on the International AIDS Conference.
At the AIDS Conference in Geneva, reports were presented on new drugs expected to improve treatment of HIV infection, to be… 
1998
1998
Making the switch--ideas for when therapy fails.
Research continues to show that early and aggressive treatment is effective for HIV treatment. However, when a patient needs to… 
1998
1998
New drugs in development.
Current treatment strategies need to be planned carefully, because there is an inadequate supply of new types of drugs… 
1997
1997
Protease inhibitors and beyond.
  • PI perspective
  • 1997
  • Corpus ID: 33056662
A new generation of protease inhibitors is entering studies. Abbott Lab's ABT-378 and Pharmacia/Upjohn's PNU-140690 are… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)